- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Awakn Life Sciences Corp (AWKN)
Awakn Life Sciences Corp stock price live, this page displays NLB AWKN stock exchange data. View the AWKN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Awakn Life Sciences Corp real time stock price chart below.
What Is the Awakn Life Sciences Corp Stock Price Today?
The Awakn Life Sciences Corp stock price today is 0.10.
What Is the Stock Symbol for Awakn Life Sciences Corp?
The stock symbol for Awakn Life Sciences Corp is ""AWKN.""
What Stock Exchange Does Awakn Life Sciences Corp Trade On?
Awakn Life Sciences Corp is listed and trades on the CBOE Canada stock exchange.
Is Awakn Life Sciences Corp a Good Stock to Buy?
Determining whether Awakn Life Sciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AWKN quote. (ISIN: CA05455W1086)
What Is the Awakn Life Sciences Corp Stock Price Today?
The Awakn Life Sciences Corp stock price today is 0.10.
What Is the Stock Symbol for Awakn Life Sciences Corp?
The stock symbol for Awakn Life Sciences Corp is ""AWKN.""
What Stock Exchange Does Awakn Life Sciences Corp Trade On?
Awakn Life Sciences Corp is listed and trades on the CBOE Canada stock exchange.
Is Awakn Life Sciences Corp a Good Stock to Buy?
Determining whether Awakn Life Sciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AWKN quote. (ISIN: CA05455W1086)
CSE
Currency in CAD
0.10
0.00(0.00%)
Closed·
Fair Value
An estimate of a Awakn Life Sciences Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.10
0.12
52 wk Range
0.06
0.18
Showing Awakn Life Sciences historical data. For real-time data please try another search
Fair Value
An estimate of a Awakn Life Sciences Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.100.12
52 wk Range
0.060.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AWKN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Awakn Life Sciences Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Awakn Life Sciences Corp Company Profile
Solvonis Therapeutics plc, a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisting of racemic ketamine, delivered intravenously, and manualized relapse prevention cognitive behavioural therapy (CBT) which is in phase 3 trials to treat severe Alcohol Use Disorder (AUD); AWKN-002, a novel MAT consisting of a patent pending proprietary S–ketamine oral thin film, and manualized relapse prevention CBT to treat AUD; and MDMA/Zydis, an investigational medicinal product entactogen that acts as a releaser and reuptake inhibitor of serotonin, norepinephrine, and dopamine. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD; with Graft Polymer (UK) PLC to develop chemical entity series programme for trauma-related mental health disorders; and with the University of Nottingham focusing on evaluating the company’s lead aminoindane series and its potential to enhance social cognition and pro-social behaviors. Solvonis Therapeutics plc is headquartered in Toronto, Canada. As of May 27, 2025, Awakn Life Sciences Corp operates as a subsidiary of Solvonis Therapeutics plc.
Compare AWKN to Peers and Sector
Metrics to compare | AWKN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAWKNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.0x | −0.5x | |
PEG Ratio | 0.00 | −0.16 | 0.00 | |
Price/Book | 0.0x | 1.3x | 2.6x | |
Price / LTM Sales | 0.0x | 1.1x | 3.2x | |
Upside (Analyst Target) | 0.0% | 43.2% | 41.2% | |
Fair Value Upside | Unlock | 24.1% | 6.2% | Unlock |
Earnings
Latest Release
Jun 11, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.